Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Prostate cancer causes around 12,000 deaths each year but the available tests are unreliable according to experts ...